project id: TCGA-UCEC; case submitter id: TCGA-DI-A2QT; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 7.9; age at index: 51; days to birth: -18835; days to death: 377; ethnicity: hispanic or latino; gender: female; race: american indian or alaska native; vital status: Dead; year of birth: 1957; year of death: 2009; age at diagnosis: 18835; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IIIC; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1186; days to sample procurement: 0; initial weight: 280.0; portion submitter id: TCGA-DI-A2QT-01A-12; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;